Assignee
POINT THERAPEUTICS INC
US·12 granted patents·7 pending applications·529 citations·filing 1998–2007
Top patents by PatentIndex Score
19 records- 0196US6703238B2Methods for expanding antigen-specific T cellsPOINT THERAPEUTICS INC·Filed 2001·Granted Mar 9, 2004·65 cites·19 claims
- 0295US7282484B2Anti-tumor agentsPOINT THERAPEUTICS INC·Filed 2006·Granted Oct 16, 2007·14 cites·12 claims
- 0394US7259138B2Anti-tumor agentsPOINT THERAPEUTICS INC·Filed 2005·Granted Aug 21, 2007·11 cites·10 claims
- 0494US6890904B1Anti-tumor agentsPOINT THERAPEUTICS INC·Filed 2000·Granted May 10, 2005·85 cites·64 claims
- 0593US6949514B2Anti-tumor agentsPOINT THERAPEUTICS INC·Filed 2003·Granted Sep 27, 2005·43 cites·52 claims
- 0693US6300314B1Hematopoietic stimulationPOINT THERAPEUTICS INC·Filed 1999·Granted Oct 9, 2001·106 cites·36 claims
- 0793US6258597B1Stimulation of hematopoietic cells in vitroPOINT THERAPEUTICS INC·Filed 1998·Granted Jul 10, 2001·123 cites·20 claims
- 0890US6770628B2Hematopoietic stimulationPOINT THERAPEUTICS INC·Filed 2001·Granted Aug 3, 2004·34 cites·21 claims
- 0986US7265118B2Regulation of substrate activityPOINT THERAPEUTICS INC·Filed 2005·Granted Sep 4, 2007·3 cites·5 claims
- 1083US7067489B2Hematopoietic stimulationPOINT THERAPEUTICS INC·Filed 2004·Granted Jun 27, 2006·14 cites·16 claims
- 1181US7276371B2Stimulation of hematopoietic cells in vitroPOINT THERAPEUTICS INC·Filed 2003·Granted Oct 2, 2007·8 cites·7 claims
- 1266US6979697B1Regulation of substrate activityPOINT THERAPEUTICS INC·Filed 1999·Granted Dec 27, 2005·23 cites·15 claims
- 1363US2008221068A1Anti-tumor agentsPOINT THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1461US2007072830A1Methods for treating diabetesPOINT THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1558US2007135354A1Hematopoietic stimulationPOINT THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1657US2006063719A1Methods for treating diabetesPOINT THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1749US2005084490A1Boroproline compound combination therapyPOINT THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 1849US2006094693A1Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditionsPOINT THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1949US2004077601A1Methods and compositions relating to isoleucine boroproline compoundsPOINT THERAPEUTICS INC·Filed 2003·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →